These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11854606)

  • 1. Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease.
    Skelly MM; Logan RF; Jenkins D; Mahida YR; Hawkey CJ
    Inflamm Bowel Dis; 2002 Mar; 8(2):93-7. PubMed ID: 11854606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.
    Smith MR; Cooper SC
    J Crohns Colitis; 2014 Aug; 8(8):890-7. PubMed ID: 24507162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern.
    Papadimitriou JC; Cangro CB; Lustberg A; Khaled A; Nogueira J; Wiland A; Ramos E; Klassen DK; Drachenberg CB
    Int J Surg Pathol; 2003 Oct; 11(4):295-302. PubMed ID: 14615824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of mycophenolate mofetil in inflammatory bowel disease.
    Tan T; Lawrance IC
    World J Gastroenterol; 2009 Apr; 15(13):1594-9. PubMed ID: 19340901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil therapy for refractory inflammatory bowel disease.
    Palaniappan S; Ford AC; Greer D; Everett SM; Chalmers DM; Axon AT; Hamlin PJ
    Inflamm Bowel Dis; 2007 Dec; 13(12):1488-92. PubMed ID: 17924566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
    Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
    Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil-induced colitis in children.
    Phatak UP; Seo-Mayer P; Jain D; Selbst M; Husain S; Pashankar DS
    J Clin Gastroenterol; 2009; 43(10):967-9. PubMed ID: 19609219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease.
    Fellermann K; Steffen M; Stein J; Raedler A; Hämling J; Ludwig D; Loeschke K; Stange EF
    Aliment Pharmacol Ther; 2000 Feb; 14(2):171-6. PubMed ID: 10651657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of injury in mycophenolate mofetil-related colitis.
    Al-Absi AI; Cooke CR; Wall BM; Sylvestre P; Ismail MK; Mya M
    Transplant Proc; 2010 Nov; 42(9):3591-3. PubMed ID: 21094821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H
    Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis.
    Liapis G; Boletis J; Skalioti C; Bamias G; Tsimaratou K; Patsouris E; Delladetsima I
    Histopathology; 2013 Nov; 63(5):649-58. PubMed ID: 24025088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil-induced colitis with graft versus host disease-like features in a liver transplant recipient.
    Patra S; Vij M; Sukanya B; Kapoor D
    Indian J Pathol Microbiol; 2012; 55(4):506-8. PubMed ID: 23455789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pointers and pitfalls of mycophenolate-associated colitis.
    Lee S; de Boer WB; Subramaniam K; Kumarasinghe MP
    J Clin Pathol; 2013 Jan; 66(1):8-11. PubMed ID: 23038687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis.
    Star KV; Ho VT; Wang HH; Odze RD
    Am J Surg Pathol; 2013 Sep; 37(9):1319-28. PubMed ID: 24076772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV
    Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
    Hafraoui S; Dewit O; Marteau P; Cosnes J; Colombel JF; Modigliani R; Cortot A; Lémann M
    Gastroenterol Clin Biol; 2002 Jan; 26(1):17-22. PubMed ID: 11938035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.